| Patent | Date |
|---|
2-methyl-aza-quinazolines
App 20220274979 - WORTMANN; Lars ; et al. | 2022-09-01 |
2-methyl-quinazolines
App 20220235013 - WORTMANN; Lars ; et al. | 2022-07-28 |
Identification And Use Of Kras Inhibitors
App 20220227729 - NGUYEN; Duy ; et al. | 2022-07-21 |
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
Grant 11,339,157 - Siegel , et al. May 24, 2 | 2022-05-24 |
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20220041752 - WANG; Zhuozhi ; et al. | 2022-02-10 |
2-(morpholin-4-yl)-1,7-naphthyridines
App 20200383991 - WORTMANN; Lars ; et al. | 2020-12-10 |
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 10,772,893 - Wortmann , et al. Sept | 2020-09-15 |
Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof
Grant 10,722,501 - Biber , et al. | 2020-07-28 |
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20190194353 - WANG; Zhuozhi ; et al. | 2019-06-27 |
Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-3(2h)-ones And 2,5,6,7-tetrahydro-3h-pyrrolo[2,1-c][1,2,4]triazol-3
App 20190160048 - BIBER; Nicole ; et al. | 2019-05-30 |
2-(morpholin-4-yl)-1,7-naphthyridines
App 20180256591 - WORTMANN; Lars ; et al. | 2018-09-13 |
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20180194857 - WANG; Zhuozhi ; et al. | 2018-07-12 |
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 9,993,484 - Wortmann , et al. June 12, 2 | 2018-06-12 |
Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)
Grant 9,944,708 - Pfizenmaier , et al. April 17, 2 | 2018-04-17 |
2-(morpholin-4-yl)-1,7-naphthyridines
App 20170216304 - WORTMANN; Lars ; et al. | 2017-08-03 |
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20170107298 - WANG; Zhuozhi ; et al. | 2017-04-20 |
2-(morpholin-4-yl)-1,7-naphthyridines
Grant 9,549,932 - Wortmann , et al. January 24, 2 | 2017-01-24 |
2-(morpholin-4-yl)-1,7-naphthyridines
App 20160287604 - Wortmann; Lars ; et al. | 2016-10-06 |
SITE-SPECIFIC ANTIBODY-MEDIATED ACTIVATION OF PROAPOPTOTIC CYTOKINES: AMAIZe (ANTIBODY-MEDIATED APOPTOSIS INDUCING CYTOKINES)
App 20150152186 - Pfizenmaier; Klaus ; et al. | 2015-06-04 |
Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)
Grant 8,980,265 - Pfizenmaier , et al. March 17, 2 | 2015-03-17 |
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20140294832 - Wang; Zhuozhi ; et al. | 2014-10-02 |
Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
App 20040053829 - Pfizenmaier, Klaus ; et al. | 2004-03-18 |
Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)
App 20040033511 - Pfizenmaier, Klaus ; et al. | 2004-02-19 |
Methods for diagnosis and treatment of tumours
App 20040001790 - Hilger, Christoph-Stephan ; et al. | 2004-01-01 |
Human FAP-alpha-specific antibodies
App 20020099180 - Pfizenmaier, Klaus ; et al. | 2002-07-25 |
| 